Astex Pharmaceuticals Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Astex Pharmaceuticals Ltd.
BeiGene’s license agreement with Leap Therapeutics covers Asia, except for Japan, along with Australia and New Zealand. Apollomics obtains rights in China and beyond to GlycoMimetics’ e-selectin antagonists.
The JP Morgan conference uptick in biopharma deal-making has begun with more than 20 deals announced this week, including the latest Bayer/Evotec partnership and Pfizer’s cancer tie-up with eFFECTOR.
Otsuka subsidiary Astex plans filing in MDS by year-end for first oral decitabine product on the back of positive Phase III comparative results.
There are lots of growth opportunities and new regulatory initiatives for devices in India, affirms a report by o3 Capital Global Advisory Private Limited, an Indian investment banking firm. But device-related issues are not high on the agenda of FDA Commissioner Hamburg during her trip to the country concluding Feb. 18.
- Drug Discovery Tools